トップ
会社
を探す
監視
リスト
決算
情報
開示
資料
お問い合わせ
有料会員申し込み
ログイン
今すぐ体験
トップ
ランキング
Nasdaq ROAランキング 1901位〜2000位
Nasdaq ROAランキング 1901位〜2000位
順位
企業名
ROA
↓
1901
INTELLIGENT PROTECTION MANAGEMENT CORP.
IPM
-42.39%
ROA
-42.39%
1902
NeuroMetrix, Inc.
NURO
-42.48%
ROA
-42.48%
1903
Annexon, Inc.
ANNX
-42.67%
ROA
-42.67%
1904
Green Giant Inc.
GGE
-42.98%
ROA
-42.98%
1905
Marblegate Acquisition Corp.
GATEU
-43.09%
ROA
-43.09%
1906
Clean Energy Technologies, Inc.
CETY
-43.23%
ROA
-43.23%
1907
Allogene Therapeutics, Inc.
ALLO
-43.24%
ROA
-43.24%
1908
Kodiak Sciences Inc.
KOD
-43.24%
ROA
-43.24%
1909
Outset Medical, Inc.
OM
-43.41%
ROA
-43.41%
1910
Generation Bio Co.
GBIO
-43.46%
ROA
-43.46%
1911
Evoke Pharma Inc
EVOK
-43.54%
ROA
-43.54%
1912
Pulmatrix, Inc.
PULM
-43.55%
ROA
-43.55%
1913
Corbus Pharmaceuticals Holdings, Inc.
CRBP
-43.67%
ROA
-43.67%
1914
REGENXBIO Inc.
RGNX
-43.68%
ROA
-43.68%
1915
Greenwave Technology Solutions, Inc.
GWAV
-43.68%
ROA
-43.68%
1916
BIODESIX INC
BDSX
-43.73%
ROA
-43.73%
1917
Spyre Therapeutics, Inc.
SYRE
-43.78%
ROA
-43.78%
1918
Viridian Therapeutics, Inc.\DE
VRDN
-43.79%
ROA
-43.79%
1919
Neuphoria Therapeutics Inc.
NEUP
-43.88%
ROA
-43.88%
1920
IOVANCE BIOTHERAPEUTICS, INC.
IOVA
-44.02%
ROA
-44.02%
1921
RECURSION PHARMACEUTICALS, INC.
RXRX
-44.11%
ROA
-44.11%
1922
Aldeyra Therapeutics, Inc.
ALDX
-44.16%
ROA
-44.16%
1923
Red Cat Holdings, Inc.
RCAT
-44.24%
ROA
-44.24%
1924
AN2 Therapeutics, Inc.
ANTX
-44.47%
ROA
-44.47%
1925
ABVC BIOPHARMA, INC.
ABVC
-44.51%
ROA
-44.51%
1926
LISATA THERAPEUTICS, INC.
LSTA
-44.56%
ROA
-44.56%
1927
ACTELIS NETWORKS INC
ASNS
-44.98%
ROA
-44.98%
1928
Reliance Global Group, Inc.
RELI
-44.99%
ROA
-44.99%
1929
DUOS TECHNOLOGIES GROUP, INC.
DUOT
-45.04%
ROA
-45.04%
1930
Climb Bio, Inc.
CLYM
-45.11%
ROA
-45.11%
1931
WW INTERNATIONAL, INC.
WW
-45.12%
ROA
-45.12%
1932
Xenetic Biosciences, Inc.
XBIO
-45.24%
ROA
-45.24%
1933
AST SpaceMobile, Inc.
ASTS
-45.62%
ROA
-45.62%
1934
FTC Solar, Inc.
FTCI
-45.64%
ROA
-45.64%
1935
Tectonic Therapeutic, Inc.
TECX
-45.66%
ROA
-45.66%
1936
CODEXIS, INC.
CDXS
-45.72%
ROA
-45.72%
1937
Kezar Life Sciences, Inc.
KZR
-45.77%
ROA
-45.77%
1938
Matterport, Inc.
MTTR
-45.79%
ROA
-45.79%
1939
Global Interactive Technologies, Inc.
GITS
-45.8%
ROA
-45.8%
1940
DELCATH SYSTEMS, INC.
DCTH
-45.81%
ROA
-45.81%
1941
Histogen Inc.
HSTO
-45.96%
ROA
-45.96%
1942
TELA Bio, Inc.
TELA
-45.97%
ROA
-45.97%
1943
Monopar Therapeutics
MNPR
-46.09%
ROA
-46.09%
1944
ClearPoint Neuro, Inc.
CLPT
-46.22%
ROA
-46.22%
1945
LENSAR, Inc.
LNSR
-46.22%
ROA
-46.22%
1946
Pluri Inc.
PLUR
-46.25%
ROA
-46.25%
1947
PLIANT THERAPEUTICS, INC.
PLRX
-46.27%
ROA
-46.27%
1948
Travere Therapeutics, Inc.
TVTX
-46.5%
ROA
-46.5%
1949
enVVeno Medical Corp
NVNO
-46.63%
ROA
-46.63%
1950
Werewolf Therapeutics, Inc.
HOWL
-46.74%
ROA
-46.74%
1951
Pyxis Oncology, Inc.
PYXS
-46.74%
ROA
-46.74%
1952
Spero Therapeutics, Inc.
SPRO
-46.81%
ROA
-46.81%
1953
Context Therapeutics Inc.
CNTX
-46.81%
ROA
-46.81%
1954
Senmiao Technology Ltd
AIHS
-47%
ROA
-47%
1955
HALLADOR ENERGY CO
HNRG
-47.17%
ROA
-47.17%
1956
Co-Diagnostics, Inc.
CODX
-47.25%
ROA
-47.25%
1957
ROCKET PHARMACEUTICALS, INC.
RCKT
-47.3%
ROA
-47.3%
1958
OnKure Therapeutics, Inc.
OKUR
-47.38%
ROA
-47.38%
1959
NOCERA, INC.
NCRA
-47.49%
ROA
-47.49%
1960
Replimune Group, Inc.
REPL
-47.6%
ROA
-47.6%
1961
Syndax Pharmaceuticals Inc
SNDX
-47.66%
ROA
-47.66%
1962
Trevi Therapeutics, Inc.
TRVI
-47.84%
ROA
-47.84%
1963
OMEROS CORP
OMER
-47.85%
ROA
-47.85%
1964
Absci Corp
ABSI
-47.86%
ROA
-47.86%
1965
Acrivon Therapeutics, Inc.
ACRV
-48.11%
ROA
-48.11%
1966
Elevation Oncology, Inc.
ELEV
-48.17%
ROA
-48.17%
1967
CVRx, Inc.
CVRX
-48.23%
ROA
-48.23%
1968
VYNE Therapeutics Inc.
VYNE
-48.36%
ROA
-48.36%
1969
Senti Biosciences, Inc.
SNTI
-48.59%
ROA
-48.59%
1970
Oric Pharmaceuticals, Inc.
ORIC
-48.6%
ROA
-48.6%
1971
DiaMedica Therapeutics Inc.
DMAC
-48.64%
ROA
-48.64%
1972
Bolt Biotherapeutics, Inc.
BOLT
-48.66%
ROA
-48.66%
1973
Inhibikase Therapeutics, Inc.
IKT
-48.66%
ROA
-48.66%
1974
Profound Medical Corp.
PROF
-48.74%
ROA
-48.74%
1975
Ventyx Biosciences, Inc.
VTYX
-48.76%
ROA
-48.76%
1976
DeFi Development Corp.
DFDV
-48.83%
ROA
-48.83%
1977
SYNLOGIC, INC.
SYBX
-48.98%
ROA
-48.98%
1978
Ainos, Inc.
AIMD
-49%
ROA
-49%
1979
Savara Inc
SVRA
-49.11%
ROA
-49.11%
1980
CHIMERIX INC
CMRX
-49.27%
ROA
-49.27%
1981
PLUG POWER INC
PLUG
-49.38%
ROA
-49.38%
1982
MeiraGTx Holdings plc
MGTX
-49.55%
ROA
-49.55%
1983
Black Diamond Therapeutics, Inc.
BDTX
-49.55%
ROA
-49.55%
1984
Axsome Therapeutics, Inc.
AXSM
-49.66%
ROA
-49.66%
1985
ECD Automotive Design, Inc.
ECDA
-49.67%
ROA
-49.67%
1986
ShiftPixy, Inc.
PIXY
-49.77%
ROA
-49.77%
1987
Kinnate Biopharma Inc.
KNTE
-49.8%
ROA
-49.8%
1988
Digimarc CORP
DMRC
-49.91%
ROA
-49.91%
1989
Sana Biotechnology, Inc.
SANA
-50.03%
ROA
-50.03%
1990
SOLAREDGE TECHNOLOGIES, INC.
SEDG
-50.05%
ROA
-50.05%
1991
GIFTIFY, INC.
GIFT
-50.05%
ROA
-50.05%
1992
SKYX Platforms Corp.
SKYX
-50.3%
ROA
-50.3%
1993
Centessa Pharmaceuticals plc
CNTA
-50.32%
ROA
-50.32%
1994
Sensei Biotherapeutics, Inc.
SNSE
-50.37%
ROA
-50.37%
1995
BIOMERICA INC
BMRA
-50.43%
ROA
-50.43%
1996
Odysight.ai Inc.
ODYS
-50.6%
ROA
-50.6%
1997
Arbutus Biopharma Corp
ABUS
-50.65%
ROA
-50.65%
1998
Cardiff Oncology, Inc.
CRDF
-50.81%
ROA
-50.81%
1999
Mind Medicine (MindMed) Inc.
MNMD
-50.94%
ROA
-50.94%
2000
Kronos Bio, Inc.
KRON
-50.99%
ROA
-50.99%
全2759件中 1901–2000件を表示中
前へ
ページ 20 / 28
次へ
対象市場
米国
NYSE
Nasdaq
日本
プライム
スタンダード
グロース
業種
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
タグ
年初来高値
年初来安値
指標を選択
マーケット指標
時価総額
PBR
PER
配当利回り
年初来騰落率
株価前日比
週間騰落率
月間騰落率
3ヶ月騰落率
6ヶ月騰落率
1年騰落率
2年騰落率
5年騰落率
損益計算書
売上高
売上成長率(%)
売上原価
売上総利益
売上総利益率(%)
研究開発費
販売管理費
営業費用
営業利益
営業利益率 (%)
経常(税引前)利益
経常(税引前)利益率(%)
法人税等合計
実効税率(%)
純利益
純利益率(%)
一株あたり利益
希薄化後一株あたり利益
調整後一株あたり利益
配当性向(%)
一株あたり配当金
調整後一株あたり配当
EBITDA
EBITDAマージン(%)
貸借対照表
現金同等物
有価証券
現金 + 有価証券
売掛金
商品及び製品
流動資産合計
有形固定資産
投資有価証券
固定資産合計
総資産
買掛金
短期借入金
一年内返済予定の長期借入金
流動負債合計
長期借入金
固定負債合計
総負債
資本金及び資本剰余金
利益剰余金
株主資本
有利子負債合計
純有利子負債
DEレシオ(%)
運転資本
キャッシュフロー計算書
減価償却費
株式報酬費用
営業キャッシュフロー
資本的支出
投資キャッシュフロー
配当金の支払額
自己株式の取得による支出
長期借入れによる収入
長期借入金の返済による支出
財務キャッシュフロー
フリーキャッシュフロー
FCFマージン(%)
その他財務指標
ROA
ROE(%)
ROCE(%)
ROIC(%)
従業員数
総還元性向